1 active not recruiting, 1 completed, 1 not yet recruiting. 1 Phase 2, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Active not recruiting 1 |
| Phase 3 | 1 | Completed 1 |
| Phase 4 | 1 | Not yet recruiting 1 |
Follow Hexavalent Vaccine: new trials by email Literature Review of Hexavalent Vaccine trials Research Report on Hexavalent Vaccine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Infant Malaria Vaccine Schedule Optimization R21 Matrix-M (R21/MM) Malaria Vaccine, Placebo, Hexavalent Vaccine - Malaria Vaccines, Malaria (Plasmodium Falciparum) | Phase 2 | Active not recruiting | PATH | 975 | 2025-05-30 | 2026-09-29 |
| Immunogenicity of Different Primary Immunization Schedules with Inactivated Poliovirus Vaccine (IPV) Plus Pentavalent Vaccine (DTwP-HBV-Hib) or with Hexavalent Vaccine (DTwP-HBV-Hib-IPV) Pentavalent vaccine, Hexavalent vaccine, Inactivated poliovirus vaccine (IPV) - Polio | Phase 4 | Not yet recruiting | International Centre for Diarrhoeal Disease Research, Bangladesh | 1190 | 2025-01-28 | 2024-12-27 |
| Concomitant Administration of a New Hexavalent Vaccine With a Meningococcal Serogroup C Conjugate Vaccine in Healthy Infants During Primary Series Immunisation Followed by Booster Vaccination Hexavalent vaccine, NeisVac-C, Prevenar 13 - Neisseria Meningitidis, Bacterial Infections | Phase 3 | Completed | Sanofi Pasteur, a Sanofi Company | 350 | 2013-04-01 | 2017-09-11 |
Bacterial Infections (1) · Malaria, Falciparum (1) · Poliomyelitis (1) · Virus Diseases (1)
International Centre for Diarrhoeal Disease Research, Bangladesh (1) · PATH (1) · Sanofi Pasteur, a Sanofi Company (1)
Burkina Faso (1) · Finland (1)